FDA: Zofran 32-mg dose pulled from market
(HealthDay)—The 32-mg, single intravenous dose of Zofran (ondansetron), an anti-nausea drug, is being removed from the market due to its potential to cause serious, even fatal, cardiac damage, according ...
Medications
Dec 06, 2012 |
not rated yet |
0
Study: Drug coverage to vary under health law
(AP)—A new study says basic prescription drug coverage could vary dramatically from state to state under President Barack Obama's health care overhaul.
Medications
Dec 04, 2012 |
not rated yet |
1
New 'pipeline' device offers new option for difficult-to-treat aneurysms
A new technology called the Pipeline embolization device (PED) shows encouraging results in patients with certain types of difficult-to-treat brain aneurysms, reports the December issue of Neurosurgery, official journal of the Congres ...
Surgery
Dec 03, 2012 |
5 / 5 (1) |
0
FDA pledges support for med tech initiative
(AP)—The Food and Drug Administration says it will collaborate with medical device manufacturers on a public-private partnership designed to speed up the development of new medical technology.
Medications
Dec 03, 2012 |
not rated yet |
0
Consumer watchdog asks FDA to revisit compounders
(AP)—A government watchdog group is calling on the Food and Drug Administration to re-inspect more than a dozen specialty pharmacies with prior records of violations, in light of a recent deadly outbreak tied to compounded ...
Medications
Nov 29, 2012 |
not rated yet |
0
FDA OKs HeartWare device for transplant patients
The Food and Drug Administration on Tuesday approved a new heart pump for patients with severe heart failure who are awaiting a heart transplant.
Cardiology
Nov 20, 2012 |
not rated yet |
0
Drug-eluting stent approved for peripheral arterial disease
(HealthDay)—The Zilver PTX Drug-Eluting Peripheral Stent has been approved by the U.S. Food and Drug Administration to treat peripheral arterial disease of the femoropopliteal artery.
Cardiology
Nov 16, 2012 |
3 / 5 (1) |
0
FDA: Company shipped tainted peanut butter
(AP)—The Food and Drug Administration says a New Mexico peanut company linked to a recent salmonella outbreak distributed peanut and almond butters even after testing showed the products were contaminated.
Diseases, Conditions, Syndromes
Nov 15, 2012 |
not rated yet |
0
Feinstein announces submission of new drug application for diagnosing parkinsonian syndromes
The Feinstein Institute for Medical Research announced today the submission of a New Drug Application to the US Food and Drug Administration (FDA) for the Fluorodopa F 18 positron emission tomography (PET) scan used to diagnose ...
Parkinson's & Movement disorders
Nov 14, 2012 |
not rated yet |
0
Drug shrinks brain tumors in children with tuberous sclerosis complex
A drug originally developed to prevent the rejection of transplanted organs has now been shown to dramatically reduce a particular kind of brain tumor in patients with tuberous sclerosis complex (TSC)—a genetic disease ...
Cancer
Nov 13, 2012 |
not rated yet |
0
|
Xarelto's approval expanded
(HealthDay)—Approval of the anti-clotting drug Xarelto (rivaroxaban) has been expanded by the U.S. Food and Drug Administration to include treating deep vein thrombosis (DVT) or pulmonary embolism.
Medications
Nov 05, 2012 |
not rated yet |
0
People in 'crowdsourcing' challenge find defibrillators in Philadelphia
Participants in a "crowdsourcing" challenge in Philadelphia used a smart phone application to locate, photograph and map more than 1,400 automated external defibrillators in public places, according to research ...
Cardiology
Nov 04, 2012 |
4.7 / 5 (3) |
0
FDA: Ameridose issues voluntary recall of all products
(HealthDay)—Ameridose, a Massachusetts-based manufacturer of sterile injectable products and oral syringes, is undergoing a voluntary recall of all unexpired products in circulation, according to an Oct. ...
Medications
Nov 02, 2012 |
not rated yet |
0
Common food preservative may slow, even stop tumor growth
Nisin, a common food preservative, may slow or stop squamous cell head and neck cancers, a University of Michigan study found.
Cancer
Oct 31, 2012 |
4.8 / 5 (6) |
0
|
A heavy price for cheaper drugs
You get what you pay for. This maxim is proving true all over again when it comes to steroid injections used to alleviate back pain. Making safe and effective versions of such drugs involves manufacturing steps that aren't ...
Medications
Oct 23, 2012 |
not rated yet |
0
